Frits Rosendaal
Frits Rosendaal
hoogleraar Klinische Epidemiologie, Leiden University Medical Center
Verified email at
Cited by
Cited by
Heart disease and stroke statistics—2012 update: a report from the American Heart Association
Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ...
Circulation 125 (1), e2-e220, 2012
Heart disease and stroke statistics-2003 update
American Heart Association
http://www. americanheart. org/downloadable/heart…, 2002
Mutation in blood coagulation factor V associated with resistance to activated protein C
RM Bertina, BPC Koeleman, T Koster, FR Rosendaal, RJ Dirven, ...
Nature 369 (6475), 64-67, 1994
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
SR Poort, FR Rosendaal, PH Reitsma, RM Bertina
Venous thrombosis: a multicausal disease
FR Rosendaal
The Lancet 353 (9159), 1167-1173, 1999
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
JW Blom, CJM Doggen, S Osanto, FR Rosendaal
Jama 293 (6), 715-722, 2005
A method to determine the optimal intensity of oral anticoagulant therapy
FR Rosendaal, SC Cannegieter, FJM Van der Meer, E Briet
Thrombosis and haemostasis 69 (03), 236-239, 1993
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
H Schunkert, IR Knig, S Kathiresan, MP Reilly, TL Assimes, H Holm, ...
Nature genetics 43 (4), 333-338, 2011
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
T Koster, JP Vandenbroucke, FR Rosendaal, H De Ronde, E Brit, ...
The Lancet 342 (8886-8887), 1503-1506, 1993
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
JP Vandenbroucke, T Koster, FR Rosendaal, E Brit, PH Reitsma, ...
The Lancet 344 (8935), 1453-1457, 1994
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
M Den Heijer, T Koster, HJ Blom, GMJ Bos, E Brit, PH Reitsma, ...
New England journal of medicine 334 (12), 759-762, 1996
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
T Koster, JP Vandenbroucke, FR Rosendaal, E Brit, AD Blann
The Lancet 345 (8943), 152-155, 1995
Incidence and mortality of venous thrombosis: a population‐based study
IA Nss, SC Christiansen, P Romundstad, SC Cannegieter, ...
Journal of thrombosis and haemostasis 5 (4), 692-699, 2007
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)[see comments]
FR Rosendaal, T Koster, JP Vandenbroucke, PH Reitsma
The risk of myocardial infarction associated with antihypertensive drug therapies
BM Psaty, SR Heckbert, TD Koepsell, DS Siscovick, TE Raghunathan, ...
Jama 274 (8), 620-625, 1995
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Homocysteine Lowering Trialists' Collaboration
Bmj 316 (7135), 894-898, 1998
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
SC Cannegieter, FR Rosendaal, E Briet
Circulation 89 (2), 635-641, 1994
Optimal oral anticoagulant therapy in patients with mechanical heart valves
SC Cannegieter, FR Rosendaal, AR Wintzen, FJM Van der Meer, ...
New England Journal of Medicine 333 (1), 11-17, 1995
Inherited thrombophilia: part 1
DA Lane, PM Mannucci, KA Bauer, RM Bertina, NP Bochkov, ...
Thrombosis and haemostasis 76 (5), 651-662, 1996
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
KM Musallam, HM Tamim, T Richards, DR Spahn, FR Rosendaal, ...
The Lancet 378 (9800), 1396-1407, 2011
The system can't perform the operation now. Try again later.
Articles 1–20